David Maron, M.D., talks with patient Dolores Benedict. (photo by Susan Urmy)
Vanderbilt-Ingram Cancer Center has been named a member of the National Comprehensive Cancer Network (NCCN), an alliance of the world's leading cancer centers, becoming the organization's 21st member.
The NCCN includes centers dedicated to improving the quality, effectiveness and efficiency of oncology practice so patients can live better lives.
“We welcome Vanderbilt-Ingram Cancer Center to the NCCN. Vanderbilt-Ingram is one of the nation's leading cancer centers, with more than $150 million in annual research funding,” said William McGivney, Ph.D., chief executive officer of NCCN. “Through their interdisciplinary collaborative methods, VICC is highly regarded as a leader in the development and delivery of high-quality cancer care.”
“Vanderbilt-Ingram is very pleased to join the NCCN,” said Jennifer Pietenpol, Ph.D., interim director at Vanderbilt-Ingram. “Promising discoveries in cancer research are being made every day, but our work is not finished until those findings are translated into advances in patient care. We are excited to join this group of cancer centers to help make that happen.”
Harold Moses, M.D., Vanderbilt-Ingram's founding director and director emeritus, noted that joining NCCN had been a longtime goal of the cancer center.
“I am very pleased that we have achieved this goal and we look forward to collaborating with our colleagues to improve cancer care for patients across the country.”
Other centers in the NCCN include City of Hope Cancer Center in Los Angeles; Memorial Sloan-Kettering Cancer Center in New York City; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; and The University of Texas M. D. Anderson Cancer Center in Houston.